General Scanning wins Voxel dispute

Article

Holographic display developer Voxel of Laguna Hills, CA, has lost its arbitration battle with former manufacturing partner General Scanning of Watertown, MA. An arbitration panel decided in favor of General Scanning and awarded the company $1.9 million

Holographic display developer Voxel of Laguna Hills, CA, has lost its arbitration battle with former manufacturing partner General Scanning of Watertown, MA. An arbitration panel decided in favor of General Scanning and awarded the company $1.9 million for engineering work performed and out-of-pocket expenses related to the production of Voxel’s Voxcam beta units.

The award has resulted in financial hardship for Voxel, as the company will be forced to secure additional equity financing to pay the damages. The decision “complicates and compromises the company’s ability to sustain ongoing activities,” CEO Allan Wolfe said.

The dispute with General Scanning has delayed Voxel’s product commercialization time line for the Voxcam systems, and, as a result, the firm has no product sales to rely on. Voxel’s new manufacturing partner is Kaiser Electro-Optics (KEO) of Carlsbad, CA, but deliveries of KEO-manufactured Voxcams are not expected until 1999 (SCAN 3/18/98).

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.